SCHEMBL29544648

SCHEMBL29544648

COc1ccc2nccc(-c3nn4c(c3Nc3cccc(Cl)c3OC)C(=O)NC[C@@H]4C)c2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK2 O43353 2/20 0.35
GAK O14976 1/20 0.35
COQ8A Q8NI60 1/20 0.35
NLK Q9UBE8 1/20 0.35
KDR P35968 1/20 0.34
NPBWR1 P48145 1/20 0.34
CCNT1 O60563 1/20 0.34
CDK9 P50750 1/20 0.34
TYK2 P29597 6/20 0.34
SRC P12931 1/20 0.33
PARP1 P09874 1/20 0.33
CDK5 Q00535 1/20 0.33
CDK5R1 Q15078 1/20 0.33
KDM4C Q9H3R0 1/20 0.32
NCF1 P14598 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
MTNR1A P48039 1/20 0.32
MTNR1B P49286 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA1D P25100 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29544685 1.00 RIPK2 (0.35) RIPK2GAKCOQ8ANLKKDR
SCHEMBL29544467 0.90 CSF1R (0.38) RIPK2GAKCOQ8ANLKKDR
SCHEMBL29544776 0.90 CSF1R (0.38) RIPK2GAKCOQ8ANLKKDR
SCHEMBL29545067 0.90 CSF1R (0.38) RIPK2GAKCOQ8ANLKKDR
SCHEMBL29544839 0.89 TYK2 (0.34) CCNT1CDK9TYK2
SCHEMBL29544718 0.84 TYK2 (0.32) CCNT1CDK9TYK2SRC
SCHEMBL29544621 0.84 TYK2 (0.34) CCNT1CDK9TYK2
SCHEMBL29544930 0.83 TYK2 (0.32) CCNT1CDK9TYK2
SCHEMBL29545127 0.83 TYK2 (0.32) CCNT1CDK9TYK2
SCHEMBL29544629 0.82 NCF1 (0.39) CDK5CDK5R1KDM4CNCF1MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022072634-A1 BICYCLIC COMPOUNDS FOR USE IN THE TREATMENT CANCER SCORPION THERAPEUTICS, INC. (US) 2022-04-07 WO disclosed